Stage IIIB Breast Cancer Completed Phase 2 Trials for Lapatinib (DB01259)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00118157Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous TamoxifenTreatment